Asolution Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.89 Cr
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.96 Cr
- Satisfied Charges ₹ 37.55 Cr
- Revenue Growth -25.49%
- Profit Growth -128.16%
- Ebitda -98.02%
- Net Worth -69.20%
- Total Assets -3.54%
About Asolution Pharmaceuticals
Asolution Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 May 2010 and has a history of 14 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.89 Cr.
The company currently has active open charges totaling ₹24.96 Cr. The company has closed loans amounting to ₹37.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nandkumar Chodankar and Laxmi Chodankar serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2010PTC202851
-
Company No.
202851
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 May 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Asolution Pharmaceuticals Private Limited offer?
Asolution Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Inflammatory and Immunosuppressant API, Blood System and Cardiovascular API, Common Disease Medicines, Anti Acne Drug, Cardiovascular Drugs & Medication, Cardiac Drugs.
Who are the key members and board of directors at Asolution Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandkumar Chodankar
|
Director | 07-May-2010 | Current |
|
Laxmi Chodankar
|
Director | 07-May-2010 | Current |
Financial Performance of Asolution Pharmaceuticals.
Asolution Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.49% decrease. The company also saw a substantial fall in profitability, with a 128.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 69.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asolution Pharmaceuticals?
In 2023, Asolution Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bliss Gvs Pharma LimitedNandkumar Chodankar is a mutual person
-
Anomalie Marketing And Services Private LimitedLaxmi Chodankar is a mutual person
Charges (Loans)
₹24.96 Cr
₹37.55 Cr
Charges Breakdown by Lending Institutions
- Others : 24.96 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Aug 2020 | Others | ₹3.47 Cr | Open |
| 17 Nov 2015 | Others | ₹21.49 Cr | Open |
| 04 Jan 2023 | Others | ₹3.00 Cr | Satisfied |
| 29 Jan 2022 | Others | ₹4.20 M | Satisfied |
| 06 Jun 2020 | Others | ₹6.00 M | Satisfied |
How Many Employees Work at Asolution Pharmaceuticals?
Asolution Pharmaceuticals has a workforce of 119 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asolution Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asolution Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.